$Editas Me_老虎社区_美港股上老虎

豫王
2018-01-24

$Editas Medicine, Inc.(EDIT)$ 这么猛莫非三期临床试验有成果了？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

Optimus
·2018-01-30
基因编辑技术估计3-5内看不到什么突破。
回复
点赞
举报
理性长期复利
·2018-01-25
这公司几时有临床产品，一期都没有进行
回复
点赞
举报

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":150466,"tweetId":"150466","gmtCreate":1516807538351,"gmtModify":1704888153712,"author":{"id":53899598696840,"idStr":"53899598696840","authorId":53899598696840,"authorIdStr":"53899598696840","name":"豫王","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Editas Medicine, Inc.(EDIT)$ 这么猛 莫非三期临床试验有成果了？</p></body></html>","htmlText":"<html><head></head><body><p>$Editas Medicine, Inc.(EDIT)$ 这么猛 莫非三期临床试验有成果了？</p></body></html>","text":"$Editas Medicine, Inc.(EDIT)$ 这么猛 莫非三期临床试验有成果了？","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/150466","repostId":0,"isVote":1,"tweetType":1,"viewCount":4518,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["EDIT"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":58,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":626560,"commentId":"626560","gmtCreate":1517290680646,"gmtModify":1517290680646,"authorId":3465382230444256,"author":{"id":3465382230444256,"idStr":"3465382230444256","authorId":3465382230444256,"name":"Optimus","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":150466,"objectIdStr":"150466","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"基因编辑技术估计3-5内看不到什么突破。","text":"基因编辑技术估计3-5内看不到什么突破。","html":"基因编辑技术估计3-5内看不到什么突破。","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":620570,"commentId":"620570","gmtCreate":1516885713223,"gmtModify":1516885713223,"authorId":3453936493680799,"author":{"id":3453936493680799,"idStr":"3453936493680799","authorId":3453936493680799,"name":"理性长期复利","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":150466,"objectIdStr":"150466","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"这公司几时有临床产品，一期都没有进行","text":"这公司几时有临床产品，一期都没有进行","html":"这公司几时有临床产品，一期都没有进行","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}

评论（2）

热议股票